(Q44184975)

30 November 2017

title

Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes (English)

1 reference

30 November 2017

1 reference

Suri D

1

1 reference

30 November 2017

Schilling R

2

1 reference

30 November 2017

Lopes AR

3

1 reference

30 November 2017

Mullerova I

4

1 reference

30 November 2017

Colucci G

5

1 reference

30 November 2017

Williams R

6

1 reference

30 November 2017

Naoumov NV

7

1 reference

30 November 2017

publication date

1 December 2001

1 reference

30 November 2017

published in

Journal of Hepatology

1 reference

30 November 2017

volume

35

1 reference

30 November 2017

issue

6

1 reference

30 November 2017

page(s)

790-797

1 reference

Hepatitis B virus immunopathogenesis

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

A cell culture assay for compounds which inhibit hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Effect of interferon-gamma on hepatitis B viral antigen expression in primary hepatocyte culture

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Lamivudine therapy of WHV-infected woodchucks.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Cytotoxic T lymphocyte control of acute lymphocytic choriomeningitis virus infection: interferon gamma, but not tumour necrosis factor alpha, displays antiviral activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Treatment with human gamma interferon of chronic hepatitis B: comparative study with alpha interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Alpha- and gamma-interferon versus alpha-interferon alone in chronic hepatitis B. A randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900215-X

7 January 2021

10.1016/S0168-8278(01)00215-X

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hsnpubjbujb65eeyg3h3ygd2vu

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_hsnpubjbujb65eeyg3h3ygd2vu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hsnpubjbujb65eeyg3h3ygd2vu

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/hsnpubjbujb65eeyg3h3ygd2vu

1 reference

30 July 2022